Skip to content

Evaluation of the safety and efficacy of the HiFocus V electrode array in adults with severe-to-profound hearing loss through analysis of post-implant benefits of the HarmonyTM HiResolutionTM Bionic Ear cochlear implant system

Evaluation of the safety and efficacy of the HiFocus V electrode array in adults with severe-to-profound hearing loss through analysis of post-implant benefits of the HarmonyTM HiResolutionTM Bionic Ear cochlear implant system - HiFocus_V

Status
Recruiting
Phases
Phase 3
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35760
Enrollment
15
Registered
2011-09-12
Start date
2012-06-27
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deafness severe-to-profound hearing loss

Interventions

None listed

Sponsors

Advanced Bionics Corporation
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * * 18 years of age * Postlingual onset of severe-to-profound hearing loss (* 4 years of age) * Sensorineural hearing loss of severe or greater degree in both ears, defined as a pure-tone average (PTA: 500 Hz, 1000 Hz, 2000 Hz, 4000 Hz) of * 70 dB HL * Marginal hearing aid benefit with appropriately fitted hearing aids, defined as a monosyllabic word score in quiet of * 50% in the best-aided condition * Proficient in the local language of the investigational center * Willingness to participate in all scheduled procedures outlined in the protocol

Exclusion criteria

Exclusion criteria: * Cochlear malformation or obstruction that would preclude adequate insertion of electrode array * Presence of additional disabilities that would prevent or interfere with participation in the required study procedures * Medical or psychological conditions that contraindicate surgery or impact the ability to manage an implanted device or to participate in the study related procedures * Evidence of central auditory lesion or compromised auditory nerve * Pregnancy at time of surgery (responsibility of the hospital)

Design outcomes

Primary

MeasureTime frame
Section 2.2 van het CIP

Secondary

MeasureTime frame
Section 2.2 van het CIP

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)